Bacopa monnieri, commonly known as Brahmi or Bacopa is a medicinal herb, used for generations in Ayurvedic medicine for supporting memory, concentration and learning capacity.
In KeenMind®, a specific standardised extract of Bacopa monnieri, known as CDRI 08, is used. KeenMind with CDRI 08 has been extensively researched for over 40 years* to support cognitive health.1-6
Discover more about CDRI 08 used in KeenMind and the key studies that support its benefits.
Bacopa monnieri in history
Bacopa monnieri, also known as Brahmi, is a small creeping herb found throughout the Indian subcontinent.
It has been used in Ayurvedic medicine for almost 3000 years.7 Throughout this time, it has been associated with a variety of health benefits including heightened learning capacity, promoting memory and concentration, as a nerve tonic and to support cardiovascular health. 7
It is the memory and learning effects of Bacopa that have attracted the most attention in the last few decades and, in doing so, have become the subject of much clinical research.
The specific extract used in KeenMind: CDRI 08
CDRI 08 is the specific Bacopa monnieri extract used by SFI Health in KeenMind. It was first researched in the 1970s by the Indian government’s Central Drug Research Institute, and has been the subject of research for more than 40 years* to support its benefits for cognitive health.
The memory supporting effect of CDRI 08 is based on numerous clinical trials. Results from these clinical trials suggest that CDRI 08 in KeenMind helps to:1-6
-
- Maintain healthy cognitive function
- Improve working memory
- Assist in learning retention
- Assist with concentration and focus as well as keeping to task and maintaining attention span
- Can be beneficial during times of stress or mild anxiety
Always read the label, use only as directed. If symptoms persist consult your healthcare professional.
Research on how CDRI 08 works
Pre-clinical studies suggest that Bacopa monnieri in CDRI 08 can help support brain function in several different ways.
Antioxidant effects to help support against oxidative stress 8,9
Neuroprotective effects involved in supporting healthy brain function8,9
Regulation of communication between brain cells and activity associated with learning and memory10
Affecting neurotransmitter systems like serotonin, dopamine and acetylcholine that involved with memory related processes11,12
Adaptogenic effects that can help support the body in times of physical and mental stress13
SFI Health Difference
Natural healthcare products can vary considerably depending on how they are produced. KeenMind is produced according to our ‘Source to Patient’ philosophy which aims to deliver a high quality and consistent extract, from batch to batch so that you can be confident that it can deliver the health benefits demonstrated in the clinical research.
This helps ensure that the natural medicine you are getting contains the exact ingredient, in the exact same amounts demonstrated in the clinical research. That’s the SFI Health difference.
CDRI 08: A Summary
Consistent quality
Through our rigorous processes, quality controls and extensive testing we help ensure that every batch of KeenMind can provide the desired health outcomes demonstrated by clinical studies.
40 years of research
Beginning in 1974* by the Central Drug Research Institute (CDRI) in India and more recently in Australia.15
6 Clinical trials
KeenMind clinical studies support its role in improving cognitive function1-6
Well tolerated and recommended worldwide
to support cognitive health, memory, concentration and learning retention.
Our source to patient philosophy
We make sure our natural medicines are consistent.
Not only do the clinical studies on our products demonstrate real health outcomes, they demonstrate the results you can expect from the same products you see on shelf. It’s all part of our Source to Patient philosophy.
References
- Stough C, et al. Psychopharmacology (Berl) 2001;156(4):481-484.
- Stough C, et al. Phytother Res 2008;22(12):1629-634.
- Roodenrys S, et al. Neuropsychopharmacology 2002;27(2):279-281.
- Raghav S, et al. Indian J Psychiatry 2006;48(4):238-242.
- Benson S, et al. Phytother Res 2014;28(4):551-559.
- Downey LA, et al. Phytother Res 2012;27(9):1407-1413.
- Singh HK. Nutrients 2013;5(2):478-497.
- Simpson et al. 2015. Evid Based Complement Alternat Med 2014; Article ID 615384.
- Bhattacharya SK et al. Phytother. Res. 2000;14: 174–179
- Mondal P, Trigun SK. Evid Based Complementary Altern Med 2015; Article ID 535013.
- Das et al. Pharmacol Biochem Behav 2002; 73 (4):893-900
- Rajan et al. Neurochem Res 2011; 36 (11):2136-44 [S14-0165].
- Rai D, et al. Pharmacol Biochem Behav 2003;75:823-830.